Ratio-Oxycodan · DIN 00608157 · 5 mg & 325 mg · tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ratio-Oxycodan · DIN 00608157
Manufacturer: Ratiopharm Inc.; listing date 1996-10-01
Health Canada: Marketed since 2017-12-21 · brand TEVA-OXYCODAN · ATC N02AJ18 OXYCODONE AND ACETYLSALICYLIC ACID · form Tablet · route Oral · ingredients OXYCODONE HYDROCHLORIDE 5 MG, ACETYLSALICYLIC ACID 325 MG · company Dismed inc. · schedule Narcotics (cdsa i)
Ratio-Oxycodan: Formulary list price $0.46 per unit (the source does not state the unit; exact figure $0.4599). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00608157)
Source record
DIN 00608157: Ratio-Oxycodan
Raw flags: sec3=Y
Item: 280808065; group id 411; item number 1013; lccId None; manufacturer id RPH
Source form: Tab; strength: 5mg & 325mg
Recorded listing: General benefit
Source prices (unrounded): $0.4599; ministry $0.4599
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00608157
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5777
Interchangeable products
Percodan · DIN 01916572 · not recorded
Shortage status: not checked (no credentials)